Global Sinus Dilation Devices Market

Global Sinus Dilation Devices Market Size, Share, Growth Analysis, By Procedure Type(Standalone sinus dilation procedures and hybrid procedures), By Patient type(Adult and pediatric patients), By End-Use(Hospitals, ambulatory surgical centers) - Industry Forecast 2024-2031


Report ID: SQMIG35A2791 | Region: Global | Published Date: February, 2024
Pages: 219 | Tables: 86 | Figures: 76

Global Sinus Dilation Devices Market News

  • In May 2022, Dalent Medical obtained additional patent protection for its Sinusleeve balloon device, strengthening the company's intellectual property rights for its proprietary device and technique used in balloon sinus dilation procedures to treat chronic sinusitis.
  • In May 2022, Medtronic successfully finalized the acquisition of Intersect ENT, a strategic move aimed at broadening its portfolio in the field of ear, nose, and throat (ENT) healthcare. This acquisition allows Medtronic to incorporate innovative products used in sinus procedures into its offerings.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Sinus Dilation Devices Market size was valued at USD 1.96 billion in 2021 and is poised to grow from USD 2.18 billion in 2022 to USD 5.13 billion by 2030, at a CAGR of 11.3% during the forecast period (2023-2030).

The Global Sinus Dilation Devices Market is a highly competitive market, with several key players dominating the industry. These players are constantly striving to introduce new and innovative products to gain a competitive edge. They are also engaging in strategic collaborations and partnerships, mergers and acquisitions, and geographical expansions to expand their market reach and strengthen their market position. The market is expected to grow significantly in the coming years due to the rising prevalence of sinusitis and other sinus-related disorders, the increasing geriatric population, and the growing demand for minimally invasive procedures. 'Medtronic (US)', 'Johnson & Johnson (US)', 'Abbott Laboratories (US)', 'Stryker Corporation (US)', 'Smith & Nephew (UK)', 'Becton, Dickinson, and Company (US)', 'Boston Scientific Corporation (US)', 'Olympus Corporation (Japan)', 'GE Healthcare (US)', 'Siemens Healthineers (Germany)', 'Philips Healthcare (Netherlands)', 'Zimmer Biomet Holdings (US)', 'Thermo Fisher Scientific Inc. (US)', 'Danaher Corporation (US)', '3M (US)', 'Hologic, Inc. (US)', 'Varian Medical Systems (US)', 'Terumo Corporation (Japan)', 'Edwards Lifesciences Corporation (US)', 'Intuitive Surgical, Inc. (US)'

One of the primary drivers of the sinus dilation devices market is the growing prevalence of chronic sinusitis worldwide. Chronic sinusitis is a common condition characterized by inflammation and infection of the sinus cavities, leading to symptoms such as facial pain, congestion, and nasal discharge. The rising incidence of chronic sinusitis is driving the demand for sinus dilation devices as a minimally invasive treatment option. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 30 million adults in the United States alone are diagnosed with chronic sinusitis each year.

Growing Demand for Minimally Invasive Procedures: There is a growing trend towards minimally invasive procedures in the field of healthcare. Patients and physicians alike are increasingly seeking treatment options that offer quicker recovery, minimal scarring, and reduced risk of complications. Sinus dilation devices, with their minimally invasive approach and favorable patient outcomes, align with this trend. The shift towards minimally invasive procedures is expected to drive the demand for sinus dilation devices in the coming years.

North America dominated the global market. The presence of leading market players and their continuous efforts in research and development has contributed to the region's dominance. The region's robust healthcare infrastructure, coupled with high adoption rates of minimally invasive procedures, has created a conducive environment for the growth of the sinus dilation devices market. One notable example of North America's dominance is the widespread adoption of balloon sinuplasty, a minimally invasive procedure that uses balloon dilation technology to treat chronic sinusitis. This innovative approach has transformed the way sinusitis is managed, offering patients a safe and effective alternative to traditional sinus surgery. As a result, balloon sinuplasty has become a cornerstone of the sinus dilation devices market in North America, contributing significantly to the region's market share.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Sinus Dilation Devices Market

Product ID: SQMIG35A2791

$5,300
BUY NOW GET FREE SAMPLE